Stereotaxis Stock Today
| STXS Stock | USD 2.23 0.06 2.76% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Stereotaxis is selling for under 2.23 as of the 27th of February 2025; that is 2.76 percent increase since the beginning of the trading day. The stock's lowest day price was 2.17. Stereotaxis has about a 33 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of January 2025 and ending today, the 27th of February 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 12th of August 2004 | Category Healthcare | Classification Health Care |
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri. The company has 84.73 M outstanding shares of which 3.26 M shares are at this time shorted by private and institutional investors with about 8.19 trading days to cover. More on Stereotaxis
Stereotaxis Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite Total, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsStereotaxis can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Stereotaxis' financial leverage. It provides some insight into what part of Stereotaxis' total assets is financed by creditors.
| |||||
Stereotaxis (STXS) is traded on NYSE MKT Exchange in USA. It is located in 710 North Tucker Boulevard, Saint Louis, MO, United States, 63101 and employs 122 people. Stereotaxis is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 188.95 M. Stereotaxis conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 84.73 M outstanding shares of which 3.26 M shares are at this time shorted by private and institutional investors with about 8.19 trading days to cover.
Stereotaxis currently holds about 30.94 M in cash with (9.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41.
Check Stereotaxis Probability Of Bankruptcy
Ownership AllocationStereotaxis shows a total of 84.73 Million outstanding shares. 30% of Stereotaxis outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Stereotaxis Ownership Details
Stereotaxis Historical Income Statement
Stereotaxis Stock Against Markets
Stereotaxis Corporate Management
| Nathan Kastelein | RD Concepts | Profile | |
| John Platt | Director Software | Profile | |
| Brian Kidd | RD Devel | Profile | |
| Patricia Esq | General Counsel | Profile | |
| Laura Garth | General Secretary | Profile | |
| Keith Galloway | Vice Operations | Profile |
Additional Tools for Stereotaxis Stock Analysis
When running Stereotaxis' price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.